Journal article
Cannabinoids shift the basal ganglia microRNA m 6 A methylation profile towards an anti-inflammatory phenotype in SIV-infected rhesus macaques
Communications biology, Vol.8(1), 1659
11/24/2025
DOI: 10.1038/s42003-025-09049-w
PMCID: PMC12644866
PMID: 41286161
Abstract
Epitranscriptomic modifications [N6-methyladenosine (m6A)] regulate various diseases, including cancer and inflammation. Despite their functional relevance in neural development and differentiation, the role of m6A modifications in HIV neuropathogenesis is unknown. Using anti-N6-methyladenosine (m6A) antibody-immunoprecipitation and microarray profiling, we identified m6A modifications in miRNAs in basal ganglia (BG) of uninfected (VEH) and SIV-infected Rhesus macaques (RMs) on combination anti-retroviral therapy (ART) and either VEH-treated (VEH/SIV/ART) or THC:CBD-treated (THC:CBD/SIV/ART). HIV/SIV infection promoted an overall hypomethylated miRNA m6A profile. While THC:CBD did not significantly impact the overall hypomethylated m6A profile, specific miRNAs predicted to target proinflammatory genes showed marked m6A hypomethylation compared to VEH-treated RMs. Additionally, specific BG m6A-modified miRNAs were detected in BG-derived extracellular vesicles. Mechanistically, the DRACH motif in the miR-194-5p seed region was significantly m6A hypomethylated in THC:CBD/SIV/ART RMs. Unlike wild-type, in-vitro transfected m6A-modified miR-194-5p mimics failed to downregulate STAT1 protein expression. Further, compared to VEH/SIV/ART RMs, THC:CBD significantly reduced m6A methylation of 44 miRNAs directly involved in regulating CNS network genes. Our findings indicate that m6A epi-transcriptomic marks in the seed nucleotides can impair miRNA function and that cannabinoids may preserve it by reducing m6A methylation levels, thus providing a mechanistic explanation underlying their anti-neuroinflammatory effects in HIV/SIV infection.
Details
- Title: Subtitle
- Cannabinoids shift the basal ganglia microRNA m 6 A methylation profile towards an anti-inflammatory phenotype in SIV-infected rhesus macaques
- Creators
- Chioma M Okeoma - New York Medical CollegeLakmini S Premadasa - Texas Biomedical Research InstituteChen S Tan - University of IowaIonita C Ghiran - Beth Israel Deaconess Medical CenterMahesh Mohan - Texas Biomedical Research Institute
- Resource Type
- Journal article
- Publication Details
- Communications biology, Vol.8(1), 1659
- DOI
- 10.1038/s42003-025-09049-w
- PMID
- 41286161
- PMCID
- PMC12644866
- eISSN
- 2399-3642
- Publisher
- Springer Nature
- Grant note
- R01DA042348 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) S10OD032443 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21/R33DA053643 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01CA218500 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DA052845 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01TR218500 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DA050169 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30AI161943 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) S10OD028732 / U.S. Department of Health & Human Services | National Institutes of Health (NIH) P51OD111033 / U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- Language
- English
- Date published
- 11/24/2025
- Academic Unit
- Microbiology and Immunology; Infectious Diseases; Iowa Neuroscience Institute; Internal Medicine
- Record Identifier
- 9985035031602771
Metrics
4 Record Views